Advertisements
Advertisements
Question
Consult the internet and find out how to make orally active protein pharmaceuticals. What is the major problem to be encountered?
Advertisements
Solution
Orally active protein pharmaceuticals contain biologically active materials such as peptides or proteins, antibodies, and polymeric beads. The body administers it orally through various formulations. It involves encapsulating protein or peptide in liposomes or formulations using penetration enhancers. People use these proteins or peptides as vaccines and for the treatment of various diseases. However, the oral administration of these peptides or proteins presents several related challenges. Once ingested, the stomach juices' proteases denature these proteins. This will nullify their effect. Therefore, it is essential to protect the therapeutic protein from digestive enzymes when it is taken orally. We inject the proteins directly into the target site to meet this requirement.
APPEARS IN
RELATED QUESTIONS
Why do children cured by enzyme-replacement therapy adenosine deaminase deficiency need periodic treatment?
Expand the Given and mention one application of each:
ELISA
Describe the role of high temperature.
ELISA is mainly used for ____________.
Explain how recombinant Insulin can be produced.
C-peptide of human insulin is ______.
ADA is an enzyme which is deficient in a genetic disorder SCID. What is the full form of ADA?
ELISA is based on:
Discuss briefly how a probe is used in molecular diagnostics.
A patient is suffering from ADA deficiency. Can he be cured? How?
